MedPath

A pilot study in the effect of mealworm protein on muscle damage in active vital elderly

Conditions
<p>Sarcopenia</p>
Registration Number
NL-OMON21181
Lead Sponsor
Radboudumc
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
69
Inclusion Criteria

60 years of older
-Registered for the Nijmegen Four Days Marches 2022
-Able to understand and perform the study procedures

Exclusion Criteria

-Type I or Type II diabetes
-Allergic or sensitive for milk proteins, or lactose intolerant
-Allergic or sensitive for shell and shellfish, like shrimp
-BMI >30kg/m2
-Diagnosed COPD
-Currently treated for cancer
-Diagnosed renal insufficiency
-Diagnosed intestinal diseases influencing the uptake of protein (i.e. active inflammatory bowel disease, Crohn’s disease)
-Consumption of other freely available protein supplements on their own during the total study period of about 4 months
-Use of statins
-Involved in a heavy resistance type exercise program

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>To investigate the impact of additional protein intake of the lesser mealworm on muscle damage (serum creatine kinase (CK) and lactate dehydrogenase (LDH)) due to repeated physical exercise (walking 30-50 km) in vital active elderly.</p>
Secondary Outcome Measures
NameTimeMethod
<p>The secondary study parameters are body composition, muscle strength, blood lipids and inflammatory markers.</p>
© Copyright 2025. All Rights Reserved by MedPath